Drugs / JM-HD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06978023 | May 2025 → Oct 2026 expected | type 2 diabetes mellitus | Chinese University of Hong Kong | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JM-HD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06978023 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a Traditional Chinese Medicine (TCM) containing a combination of four herbs (Jinmai, abbreviated as JM)” NCT06978023 ↗ |